Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Cohort study (9171 patients, 447 hospitals, 55 countries) found pulmonary complication rates and postoperative SARS-CoV-2 infection rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; OR 0.62; 95%CI, 0.44-0.86 and 2.1% vs 3.6%, 0.53, 0.36-0.76 respectively).

Source:

Journal of Clinical Oncology